Overview

An Evaluation of the Long-Term Safety of CSF-1 in Presbyopic Subjects

Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This is a 4 or 11 visit, multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the long-term safety of CSF-1 compared with vehicle in presbyopic subjects.
Phase:
Phase 3
Details
Lead Sponsor:
Orasis Pharmaceuticals Ltd.